周航宇;姜淮芜;王明佳;

• 1:泸州医学院

摘要(Abstract)：

<正>5-羟色胺(5-HT)是一种吲哚衍生物,最早在血清中发现,又名血清素,广泛存在于哺乳动物中,且在大脑皮层和神经突触内含量高,是一种抑制性神经递质。在外周组织中,5-HT是一种强血管收缩剂和平滑肌收缩刺激剂。5-HT可以经单胺氧化酶催化成5-羟色醛和5-羟吲哚乙酸,随尿液排出体外。它作为神经递质和血管活性物质,广泛分布在周围组织和中枢神经系统中,在感觉运动、心血管功能、

关键词(KeyWords)： 5-羟色胺;受体;肿瘤

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 周航宇;姜淮芜;王明佳;

Email:

DOI:

参考文献(References)：

• [1]Fava M,Kendler KS.Major depressive disorder[J].Neuron,2000,28(2):335-341.
• [2]Filip M,Bader M.Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system[J].Pharmacol Rep,2009,61(5):761-777.
• [3]王静,诸琦.5-羟色胺受体及转运体在肠易激综合征发病机制中的作用[J].上海交通大学学报(医学版),2008,28(8):1051-1054.
• [4]Drummond PD.Effect of tryptophan depletion on symptoms of motion sickness in migraineurs[J].Neurology,2005,65(4):620-622.
• [5]Clada P,Puig M,Amarg6s-Bosch M,et al.The therapeutic role of5-HT3A and 5-HT2A receptors in depression[J].J Psychiatr Neurosci,2004,29(4):252-265.
• [6]Dueottet C,Griebel G,Belzung C.Effects of the selective nonpeptide corticotropin-releasing factor receptor1 antagonist antalarmin in the chronic mild stress model of depression in mice[J].Prog Neuropsychopharmacol Biol Psychiatry,2003,27(4):625-631.
• [7]易传安,胡祥上,马晓凯,等.大鼠海马内5-羟色胺及其受体5-HT2A的表达[J].解剖学杂志,2011,34(4):508-510.
• [8]Brea J,Castro-Palomino J,Yeste S,et al.Emerging opportunities and concern for drug discovery at serotonin 5-HT2B receptors[J].Curr Top Med Chem,2010,10(5):493-503.
• [9]Gomez-Merino D,Bequet F,Berthelot M,et al.Evidence that the branched-chain amino acid L-valine prevents exercise-induced release of 5-HT in rat hippocampus[J].Int J Sports Med,2001,22(5):317-322.
• [10]Nelson JC,Portera L,Leon AC.Are there differences in the symptoms that respond to a selective 5-hydroxytryptamine or norepinephrine reuptake inhibitor[J].Bid Psychiatry,2005,57(12):1535-1542.
• [11]杨仙珊,张晶,李晓晴,等.5-羟色胺2A受体阻断剂对大鼠肝脏再生的影响[J].胃肠病学和肝病学杂志,2011,20(1):71-73.
• [12]刘妍虹,王利民.5羟色胺2B受体(5-HT2BR)在膀胱癌中表达及其临床意义[J].现代肿瘤医学,2009,17(3):522-525.
• [13]Borman RA,Tilford NS,Harmer DW,et al.5-HT(2B)receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro[J].Br J Pharmacol,2002,135(5):1144-1151.
• [14]Drossman DA.Psychosocial aspects of the functional gastrointestinal disorders[J].Gut,1999,45(2):25-30.
• [15]Takada K,Sakurai-Yamashita Y,Yamashita K,et al.Regional difference in correlation of 5-HT4 receptor distribution with cholinergic transmission in the guinea pig stomach[J].Eur J Pharmacol,1999,374(3):489-494.
• [16]Glatzle J,Sternini C,Robin C,et al.Expression of 5-HT3 receptors in the rat gastrointestinal tract[J].Gastroenterology,2002,123(1):217-226.
• [17]Claeysen S,Sebben M,Becamel C,et al.5-HT4 receptor-Wikipedia,the free encyclopedia[J].Mol Pharmacol,1999,55(5):910-920.
• [18]Lacy BE,Yu S.Tegaserod:a new 5-HT4 agonist[J].Gastroenterol,2002,34(1):27-33.
• [19]Tonini M,Vicini R,Cervio E,et al.5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum[J].Gastroenterology,2005,129(5):1557-1566.
• [20]陈燕,李正阳,杨焱,等.5-HT2B受体在不同亚型肠易激综合征模型大鼠发病中的作用[J].南京医科大学学报(自然科学版),2012,32(5):609-615.
• [21]于建勋,赵玉贞,刘淑娴,等.胃癌患者胃液中5-羟色胺含量的检测及临床意义[J].白求恩医科大学学报,1990,16(4):376-378.
• [22]张冲,张金山,黄威权,等.5-羟色胺及其受体与人肝细胞性肝癌增殖的关系[J].中华肝脏病杂志,2000,8(6):345.
• [23]何兰杰,陈凌,李国徽.大鼠阴茎组织5-HT 2受体表达及其在糖尿病ED中变化的研究[J].陕西医学杂志,2009,38(9):1111-1114.
• [24]白崇峰,黎涛,马春山,等.5-HT2B受体阻断剂在去甲肾上腺素诱导大鼠心肌肥厚中的作用[J].实用医药杂志,2012,29(2):149-151.
• [25]胡梦云,傅继华.肝脏5-羟色胺相关系统与肝脏疾病[J].药学与临床研究,2012,20(1):63-66.
• [26]Fenik P,Veasey SC.Pharmacological characterization of sel-otorlerglc receptor activity in the hypoglossal nucleus[J].Am J Respir Crit Care Med,2003,167(4):563-569.
• [27]Ogasa T,Ray AD,Michlin CP,et al.Systemic administration of serotonin2A/2C agonist improves upper airway stability in Zucker rats[J].Am J Respir Crit Care Med,2004,170(7):804-810.
• [28]Besnard S,Masse F,Verdaguer M,et al.Time-and doseprelated effects of three 5-HT receptor ligands on the genioglossus activity in anesthetized and conscious rats[J].Sleep Breath,2007,11(4):275-284.
• [29]钟益珏,张成,王广发.5-羟色胺2受体激动剂及拮抗剂对大鼠睡眠呼吸暂停的影响[J].中华结核和呼吸杂志,2010,33(5):350-353.
• [30]陈晨,王邦茂.5-羟色胺及其受体与癫痫关系的研究进展[J].国际神经病学神经外科学杂志,2010,37(4):325-328.
• [31]秦娟娟,李云峰,刘振华,等.5-羟色胺及其受体与抑郁症[J].国际药学研究杂志,2012,39(5):409-413.
• [32]Jemal A,Siegel R,Ward E,et al.Cancer statistics 2008[J].CA Cancer J Clin,2008,58(4):71-96.
• [33]Alberts SR,Cervantes A,van de Velde CJH.Gastric cancer:epidemiology,pathology and treatment[J].Ann Oncol,2003,14(suppl 2):1131-1136.
• [34]Kelley JR,Duggan JM.Gastric cancer epidemiology and risk factors[J].J Clin Epidemiol,2003,56(1):1-9.
• [35]Roder DM.The epidemiology of gastric cance[J].Gastric Cancer,2002,5(suppl 1):5-11.
• [36]Bryan J,Dicken MD,David L,et al.Gastric adenocarcinoma review and considerations for future directions[J].Ann Surg,2005,241(1):27-39.
• [37]Smith AM,Watson SA.Gastrin and gastrin receptor activation:an early event in the adenoma-carcinoma sequence[J].Gut,2000,47(6):820-824.
• [38]方艺,于燕妮,胡军.胃泌素和5-羟色胺的表达与胃癌临床分期及分化程度的相关性研究[J].中国医师进修杂志,2006,29(10):4-5.